Correlation Between Acasti Pharma and Bio Path
Can any of the company-specific risk be diversified away by investing in both Acasti Pharma and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acasti Pharma and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acasti Pharma and Bio Path Holdings, you can compare the effects of market volatilities on Acasti Pharma and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acasti Pharma with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acasti Pharma and Bio Path.
Diversification Opportunities for Acasti Pharma and Bio Path
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Acasti and Bio is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Acasti Pharma and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Acasti Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acasti Pharma are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Acasti Pharma i.e., Acasti Pharma and Bio Path go up and down completely randomly.
Pair Corralation between Acasti Pharma and Bio Path
If you would invest 337.00 in Acasti Pharma on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Acasti Pharma or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Acasti Pharma vs. Bio Path Holdings
Performance |
Timeline |
Acasti Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Good
Bio Path Holdings |
Acasti Pharma and Bio Path Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acasti Pharma and Bio Path
The main advantage of trading using opposite Acasti Pharma and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acasti Pharma position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.Acasti Pharma vs. Tonix Pharmaceuticals Holding | Acasti Pharma vs. Jaguar Animal Health | Acasti Pharma vs. Ibio Inc | Acasti Pharma vs. Akari Therapeutics PLC |
Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |